Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|---|
Filter | GSE201858 | ||||||||
GSM6077235 |
Uninfected, untreated, control organoids
|
SRA | 1 |
|
Rachel Klapper Zwick | Nov 27, 2023 | |||
GSM6077236 |
Uninfected, 4-hydroxytamoxifen treated, control organoids
|
SRA | 1 |
|
Rachel Klapper Zwick | Nov 27, 2023 | |||
GSM6077237 |
Dual guide RNA targeting Ppard infected, untreated, control organoids, 1
|
SRA | 1 |
|
Rachel Klapper Zwick | Nov 27, 2023 | |||
GSM6077238 |
Dual guide RNA targeting Ppard infected, untreated, control organoids, 2
|
SRA | 1 |
|
Rachel Klapper Zwick | Nov 27, 2023 | |||
GSM6077239 |
Ppard mutant organoid line 1: transduced with Ppard-targetting dual guide RNAs, treated with 4-hydroxytamoxifen, 1
|
SRA | 1 |
|
Rachel Klapper Zwick | Nov 27, 2023 | |||
GSM6077240 |
Ppard mutant organoid line 1: transduced with Ppard-targetting dual guide RNAs, treated with 4-hydroxytamoxifen, 2
|
SRA | 1 |
|
Rachel Klapper Zwick | Nov 27, 2023 | |||
GSM6077241 |
Dual guide RNA targeting Cdx1 infected, untreated, control organoids
|
SRA | 1 |
|
Rachel Klapper Zwick | Nov 27, 2023 | |||
GSM6077242 |
Cdx1 mutant organoid line 1: transduced with Ppard-targetting dual guide RNAs, treated with 4-hydroxytamoxifen
|
SRA | 1 |
|
Rachel Klapper Zwick | Nov 27, 2023 |